US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil 04/07/2008 by Tatum Anderson for Intellectual Property Watch 1 Comment By Tatum Anderson for Intellectual Property Watch Indian generic manufacturers may be allowed to export a cheaper HIV/AIDS treatment to middle-income countries if US pharmaceutical company Gilead fails to win a patent for the drug in India. And a turnaround by the United States on the same patent may influence the outcome. Currently, the largest […]
Green Intellectual Property Scheme: An Innovation Today For Innovations Tomorrow 27/06/2008 by Intellectual Property Watch Leave a Comment By Itaru Nitta, Green Intellectual Property Project, Geneva, Switzerland Since the current IP framework has been shaped in wealthy societies of the North, accompanied by fertile markets, the North is required to rebuild the framework if they attempt to expand it to the South without substantial markets. The revamped regime, namely the “Green Intellectual Property […]
La aprobación brasileña de la investigación sobre células madre embrionarias podría fomentar la protección por patente 09/06/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Por Claudia Jurberg para Intellectual Property Watch RÍO DE JANEIRO – Hace poco, el Tribunal Supremo de Brasil aprobó, por un margen estrecho de 6 a 5, la investigación sobre células madre embrionarias, luego de analizar el tema durante tres días. La votación del 29 de mayo se realizó luego de una prolongada lucha que […]
Latest Available Text Of The CBD Decision On Access And Benefit-Sharing 05/06/2008 by Kaitlin Mara for Intellectual Property Watch 1 Comment Note: the final decisions of convention on biological diversity governing body are available here. A decision on a way forward on a global access and benefit-sharing regime was reached at a meeting of the parties to the Convention on Biological Diversity from 19 to 30 May in Bonn. The main body of the document describes steps needed to reach international consensus on the content of such a regime. Annex I of the document sets out a draft text for the international regime, and annex II contains terms of reference for expert technical and legal groups whose creation is mandated by the main text.
Brazil Approval Of Embryonic Stem Cell Research Could Boost Patenting 03/06/2008 by Claudia Jurberg for Intellectual Property Watch 1 Comment By Claudia Jurberg for Intellectual Property Watch RIO DE JANEIRO – After three days of consideration, the Brazilian Supreme Court last week approved by a narrow 6 to 5 margin research involving embryonic stem cells. The 29 May vote followed a protracted fight that consumed three years. The case arose after former Brazilian Attorney General […]
Brazil Declares Patented AIDS Drug Of Public Interest, Could Expand Access 22/04/2008 by Claudia Jurberg for Intellectual Property Watch 1 Comment By Claudia Jurberg for Intellectual Property Watch The Brazilian government recently declared the drug Tenofovir, used against HIV/AIDS, to be of public interest. The announcement signals the country’s interest in using an option to avoid the patent on the drug and possibly beginning the process of issuing a compulsory license for the antiretroviral which is […]
Innovative Partnership To Create Another Patent-Free Malaria Drug 17/04/2008 by Catherine Saez, Intellectual Property Watch 1 Comment By Catherine Saez After an innovative partnership between a non-governmental group and a pharmaceutical company led to a new cheap non-patented drug against malaria being available in Africa in 2007, the model is being implemented again with another new non-patented anti-malarial drug being delivered to South American patients. The Drugs for Neglected Diseases initiative (DNDi), […]
Brazil Wrestles With Decision On GM Corn, Seed Patenting 17/03/2008 by Claudia Jurberg for Intellectual Property Watch Leave a Comment By Claudia Jurberg for Intellectual Property Watch RIO DE JANEIRO – After 10 years of debate, Brazil approved in February the commercialisation of two varieties of genetically modified corn, a highly contentious decision in the country that has become linked to concerns about seed patenting by multinational companies. Now, sale of GM corn in the […]
Les négociations bilatérales pèsent sur la politique commerciale multilatérale définie à Genève selon un groupe d’experts 04/02/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Par Kaitlin Mara et William New Un groupe d’experts gouvernementaux et non gouvernementaux a souligné, la semaine dernière, les conséquences importantes que les négociations menées par les principales économies en vue de conclure des accords de libre-échange bilatéraux ont sur les règles de politique commerciale multilatérale définies à Genève. Ces experts, spécialistes des questions de […]
Expertos observan gran repercusión de los acuerdos comerciales bilaterales en la formulación de políticas de Ginebra 04/02/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Por Kaitlin Mara y William New Un panel integrado por expertos en cuestiones de propiedad intelectual y biodiversidad gubernamentales y no gubernamentales destacó la semana pasada el gran impacto que tienen las negociaciones comerciales bilaterales de las principales economías del mundo en la formulación de políticas multilaterales en Ginebra. Los expertos expusieron sus razones el […]